BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9132444)

  • 1. [Heart failure and circulatory control peptides].
    Takeshita A
    Nihon Naika Gakkai Zasshi; 1994 Jan; 83(1):138-42. PubMed ID: 9132444
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium retention in heart failure.
    Cannon PJ
    Cardiol Clin; 1989 Feb; 7(1):49-62. PubMed ID: 2523241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
    Packer M
    Circulation; 1988 Jun; 77(6 Pt 2):I64-73. PubMed ID: 2967129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Receptors for vasoactive peptides in experimental hypertension and cardiac insufficiency].
    Schiffrin EL; St-Louis J
    Union Med Can; 1988 Feb; 117(1):133-6. PubMed ID: 2836981
    [No Abstract]   [Full Text] [Related]  

  • 5. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atrial natriuretic factor in cardiovascular diseases].
    Nakamura M; Arakawa N; Hiramori K
    Kokyu To Junkan; 1991 Oct; 39(10):971-8. PubMed ID: 1836068
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormones and hemodynamics in heart failure.
    Schrier RW; Abraham WT
    N Engl J Med; 1999 Aug; 341(8):577-85. PubMed ID: 10451464
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; de Faria DB
    Rev Port Cardiol; 1989 Feb; 8(2):129-48. PubMed ID: 2576635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasopeptidase inhibition: a new pharmacological principle in the treatment of hypertension and cardiac insufficiency].
    Kolloch R; Offers E
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1342-7. PubMed ID: 11719860
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathophysiology of congestive heart failure].
    Luzza F; Bruni F; Rizzo F; Carerj S
    Minerva Cardioangiol; 2002 Jun; 50(3):209-19. PubMed ID: 12107401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial natriuretic peptide as angiotensin II antagonist. A new therapeutic principle?].
    Pfaffendorf M
    Med Monatsschr Pharm; 1992 Jun; 15(6):169-77. PubMed ID: 1535414
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
    Karlsen FM; Kamper AL
    Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
    [No Abstract]   [Full Text] [Related]  

  • 18. [Natriuretic peptides and cardiomyopathy].
    Nishigaki K; Fujiwara H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():95-100. PubMed ID: 15506346
    [No Abstract]   [Full Text] [Related]  

  • 19. [Natriuretic peptides in patients with ischemic heart disease].
    Yoshimura M; Ogawa H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():88-92. PubMed ID: 15506344
    [No Abstract]   [Full Text] [Related]  

  • 20. Converting enzyme inhibitors and renal function in cardiac failure.
    Robertson JI; Richards AM
    Kidney Int Suppl; 1987 May; 20():S216-9. PubMed ID: 3037172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.